Cardioversion and risk of adverse events with dabigatran versus warfarin: a nationwide cohort study

Jannik Langtved Pallisgaard, Tommi Bo Lindhardt, Morten Lock Hansen, Anne-Marie Schjerning, Jonas Bjerring Olesen, Laila Staerk, Christian Torp-Pedersen, Gunnar Hilmar Gislason

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

23 Citationer (Scopus)
261 Downloads (Pure)
OriginalsprogEngelsk
Artikelnummere0141377
TidsskriftPLoS ONE
Vol/bind10
Udgave nummer10
Antal sider11
ISSN1932-6203
DOI
StatusUdgivet - 2015

Fingeraftryk Dyk ned i forskningsemnerne om 'Cardioversion and risk of adverse events with dabigatran versus warfarin: a nationwide cohort study'. Sammen danner de et unikt fingeraftryk.

  • Citationsformater

    Pallisgaard, J. L., Lindhardt, T. B., Hansen, M. L., Schjerning, A-M., Olesen, J. B., Staerk, L., Torp-Pedersen, C., & Gislason, G. H. (2015). Cardioversion and risk of adverse events with dabigatran versus warfarin: a nationwide cohort study. PLoS ONE, 10(10), [e0141377]. https://doi.org/10.1371/journal.pone.0141377